A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Japanese Healthy Men.
Phase of Trial: Phase I
Latest Information Update: 06 May 2009
At a glance
- Drugs AZD 3199; AZD 3199
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 06 May 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov
- 06 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 17 Nov 2008 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.